BIIB shares have jumped around 50% in early trading activity Wednesday.
Plus, we take looks at Eli Lilly and Raytheon Technologies after positive news developments for both companies.
This biopharmaceutical firm shows promise.
I'm bullish long term, but for now, can BMY generate follow-through buying?
Let's check the charts and indicators of the IBB.
Here's what aggressive traders could do now.
This stock is in a technical state of weakness and add that to the eroding fundamentals.
Here's how traders can play the stock.
Buyers of the biopharmaceutical's stock are being more aggressive than sellers.
In light of the stock market's weakness, CYTK has shown impressive strength.